Mathes Tim, Pieper Dawid, Antoine Sunya-Lee, Eikermann Michaela
Institute for Research in Operative Medicine, Faculty of Health - School of Medicine, Witten/Herdecke University, Ostmerheimer Str. 200, Building 38, D-51109 Cologne, Germany.
Cancer Epidemiol. 2014 Jun;38(3):214-26. doi: 10.1016/j.canep.2014.03.012. Epub 2014 Apr 24.
The use of oral anticancer agents increased steadily in the last decades. Although oral anticancer agent adherence is important for a successful treatment, many patients are insufficiently adherent.
To evaluate adherence influencing factors in patients taking oral anticancer agents.
A systematic literature search was performed in Medline and Embase. Titles and abstracts and in case of relevance, full-texts were screened according to predefined inclusion criteria. The risk of bias was assessed. Both were carried out independently by two reviewers. Relevant data on study characteristics and results were extracted in standardized tables by one reviewer and checked by a second. A meta-analysis was not performed because of clinical and methodological heterogeneity between the studies to avoid misleading results. Data were synthesized in narrative way using a standardized procedure.
Twenty-two relevant studies were identified. The study quality was moderate. Especially the risk of bias regarding the measurement of influencing factors and adherence was mostly unclear. Social support, intake of aromatase inhibitors, and lower out-of-pocket costs for OACA seem to have a positive effect on adherence. Depression and the number of different medications seem to have a negative effect on adherence. Low age and very high age seem to be associated with lower adherence. The remaining factors showed either mostly no influence or were heterogeneous regarding the effect direction and statistical significance.
There are some factors that seem to have influence on adherence in patients taking OACA. However, due to the heterogeneity no general conclusions can be made also for these factors that can be applied to all indications, medications, settings, countries etc. The results should rather be considered as indications for factors that can have an influence on adherence to OACA.
在过去几十年中,口服抗癌药物的使用稳步增加。尽管口服抗癌药物的依从性对于成功治疗很重要,但许多患者的依从性不足。
评估服用口服抗癌药物患者的依从性影响因素。
在Medline和Embase中进行了系统的文献检索。根据预先定义的纳入标准筛选标题、摘要,如有相关性则筛选全文。评估偏倚风险。这两项工作均由两名审阅者独立进行。一名审阅者以标准化表格提取有关研究特征和结果的相关数据,并由另一名审阅者进行核对。由于研究之间存在临床和方法学异质性,为避免产生误导性结果,未进行荟萃分析。使用标准化程序以叙述方式综合数据。
确定了22项相关研究。研究质量中等。特别是关于影响因素测量和依从性的偏倚风险大多不明确。社会支持、芳香酶抑制剂的摄入以及口服抗癌药物较低的自付费用似乎对依从性有积极影响。抑郁和不同药物的数量似乎对依从性有负面影响。低年龄和高年龄似乎与较低的依从性相关。其余因素大多显示无影响,或者在效应方向和统计学意义方面存在异质性。
有一些因素似乎对服用口服抗癌药物患者的依从性有影响。然而,由于存在异质性,对于这些因素也无法得出可应用于所有适应症、药物、环境、国家等的一般性结论。这些结果应更多地被视为可能影响口服抗癌药物依从性的因素的指示。